SCHEMBL7970170

SCHEMBL7970170

CCCCCCCCCC(=O)c1ccc(OCc2ccc(/C=C3/SC(=S)NC3=O)cc2)c(CCC)c1O

nearest known ligand 0.79

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CTSD P07339 20/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7970172 1.00 CTSD (0.79) CTSD
SCHEMBL7971823 0.88 CTSD (1.00) CTSD
SCHEMBL7971818 0.88 CTSD (1.00) CTSD
SCHEMBL7971821 0.88 CTSD (1.00) CTSD
SCHEMBL7969920 0.85 CTSD (1.00) CTSD
SCHEMBL7969923 0.85 CTSD (1.00) CTSD
SCHEMBL7969919 0.85 CTSD (1.00) CTSD
SCHEMBL7969454 0.81 CTSD (0.49) CTSD
SCHEMBL7971652 0.80 CTSD (1.00) CTSD
SCHEMBL7971649 0.80 CTSD (1.00) CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed